Search research articles
Contact Us
Filters
Showing results (751-760 of 811) with videos related to
Page
of 82
Sort By:
British Journal of Pharmacology
|
May 22, 2020
Effect of selective I<sub>K,ACh</sub> inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation
Merle Friederike Fenner, Helena Carstensen, Sarah Dalgas Nissen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2025
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
S Martín-Lluesma, U Dafni, K Vervita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2018
T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
R Andersen, T H Borch, A Draghi, et al.
Nature Communications
|
August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Kevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Medicine
|
December 10, 2021
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
Paolo A Ascierto, Hao Tang, Sonia Dolfi, et al.
The Journal of Clinical Investigation
|
November 23, 2021
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
Nikolaj Pagh Kristensen, Christina Heeke, Siri A Tvingsholm, et al.
Cancer Immunology Research
|
July 4, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T Cells
Marlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
Frontiers in Oncology
|
December 9, 2022
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Uffe Klausen, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, et al.
Nature Communications
|
November 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, et al.
Page
of 82
Search research articles
Search
Showing results (751-760 of 811) with videos related to
Sort By:
Page
of 82
British Journal of Pharmacology
|
May 22, 2020
Effect of selective I<sub>K,ACh</sub> inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation
Merle Friederike Fenner, Helena Carstensen, Sarah Dalgas Nissen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2025
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
S Martín-Lluesma, U Dafni, K Vervita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2018
T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
R Andersen, T H Borch, A Draghi, et al.
Nature Communications
|
August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Kevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Medicine
|
December 10, 2021
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
Paolo A Ascierto, Hao Tang, Sonia Dolfi, et al.
The Journal of Clinical Investigation
|
November 23, 2021
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
Nikolaj Pagh Kristensen, Christina Heeke, Siri A Tvingsholm, et al.
Cancer Immunology Research
|
July 4, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T Cells
Marlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
Frontiers in Oncology
|
December 9, 2022
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Uffe Klausen, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, et al.
Nature Communications
|
November 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, et al.
Page
of 82